MusclePharm Corporation Interest Expense, Other
MusclePharm Corporation reported Interest Expense, Other of $235.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-17.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2021-11-17
- MusclePharm Corporation interest expense, other for the quarter ending 2021-09-30 was $235.00K, a 5.62% decline year-over-year.
- MusclePharm Corporation interest expense, other for the quarter ending 2021-06-30 was $235.00K, a 34.29% increase year-over-year.
- MusclePharm Corporation interest expense, other for the quarter ending 2021-03-31 was $227.00K, a 44.59% increase year-over-year.
- MusclePharm Corporation interest expense, other for the quarter ending 2020-09-30 was $249.00K, a 53.70% increase year-over-year.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month |
|---|---|---|---|
| 2021-09-30 | $235.00K 10-Q · filed 2021-11-17 | $470.00K derived: sum of 2 quarters · filed 2021-11-17 | $693.00K 10-Q · filed 2021-11-17 |
| 2021-06-30 | $235.00K 10-Q · filed 2021-08-16 | $443.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $227.00K 10-Q · filed 2021-05-24 | ||
| 2020-09-30 | $249.00K 10-Q · filed 2021-11-17 | $424.00K derived: sum of 2 quarters · filed 2021-11-17 | $581.00K 10-Q · filed 2021-11-17 |
| 2020-06-30 | $175.00K 10-Q · filed 2021-08-16 | $332.00K 10-Q · filed 2021-08-16 | |
| 2020-03-31 | $157.00K 10-Q · filed 2021-05-24 | ||
| 2019-09-30 | $162.00K 10-Q · filed 2020-11-24 | $326.00K derived: sum of 2 quarters · filed 2020-11-24 | $619.00K 10-Q · filed 2020-11-24 |
| 2019-06-30 | $164.00K 10-Q · filed 2020-11-24 | $457.00K 10-Q · filed 2020-11-24 |